What’s more, our data suggested that SCD1 might be of a pivotal role in the progression of ccRCC and could be integrated to the current model to predict survival of ccRCC as an independent prognosis factor, which might guide the clinical therapies. The gene discussed is SCD; the disease is nonpapillary renal cell carcinoma.